medicament 3004909214

💊 Medicament (Drug Products) | HS Code 3003/3004 Category Analysis

🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy 📌 1. Product Definition & Classification: Do You Really Understand "Medicament"?

Medicament, in international trade, refers to pharmaceutical products intended for the treatment or prevention of diseases in humans or animals. Unlike simple food supplements or cosmetic preparations, medicaments have specific therapeutic claims and active ingredients.

The classification generally hinges on two main factors: * State of Preparation: Is it mixed with other substances (HS 3003) or put up for retail sale in measured doses/formulations (HS 3004)? * Active Ingredient: Does it contain alkaloids or derivatives (e.g., penicillin, antibiotics, hormones), or is it a "other" medicament?

⚠️ Key Distinction: * HS 3003: Drugs mixed with other substances, not put up for retail sale in measured doses (e.g., bulk pharmaceutical chemicals, raw powder forms). * HS 3004: Medicaments (including those containing antibiotics, hormones, etc.) put up in measured doses or in forms/packings for retail sale (e.g., tablets, capsules, ampoules, blister packs).

📦 2. HS Code Classification Details (2026 Latest Tariff Authority Cross-Reference)

Based on the provided data, the potential HS Codes for "Medicament" are listed below. Note that 3003 items are typically bulk/raw, while 3004 items are finished retail products.

🔍 Critical Reminder: * If the product is a finished dosage form (pill, capsule, bottle of liquid), it MUST be classified under 3004. * If the product is a bulk chemical/powder not intended for direct consumer sale, it may fall under 3003. * Misclassification between 3003 and 3004 can lead to severe customs penalties, as the physical state and regulatory requirements differ significantly.

💰 3. 2026 Latest Tariff Rate Details (Including Surtaxes & Policy Add-ons)

✅ Applicable Country: USA (US) ✅ Origin: China (CN) ✅ Effective Date: 2025年11月10日起 (From Nov 10, 2025 onwards)

🎯 1. 3003.49.00.00 & 3003.90.01.90 —— Bulk Medicaments (Non-Retail)

📌 Explanation: * Base Rate 0%: The standard Most Favored Nation (MFN) rate for many pharmaceutical goods is 0%. * Section 122 10%: This specific surtax applies to these bulk medicament codes from China. It is crucial to verify if this "Section 122" refers to a specific trade remedy or a newly implemented tariff line in your specific 2026 context. In many recent analyses, this 10% is an additional cost on top of the base rate. * Total Cost: 10% of the declared CIF value.

🎯 2. 3004.49.00.50 & 3004.49.00.70 —— Retail-Ready Medicaments

📌 Note: * Even though the physical product is different (finished vs. bulk), the tax rate remains 10% in this specific classification scenario. * Why? The underlying tariff structure for "Medicaments" from China in this dataset consistently applies the 10% surcharge. * Regulatory Note: HS 3004 items often face stricter FDA/health regulatory scrutiny than 3003 items. Ensure all drug approval documents (NDA, ANDA, or OTC monograph compliance) are ready for customs and FDA inspection.

🛠️ 4. Customs Clearance Practical Advice (Battle-Hardened Pitfall Avoidance Guide)

✅ 1. Document Checklist (Non-Negotiable)

✅ 2. Declaration Techniques (Key Mnemonics)

🔥 "Form Determines Code, Origin Drives Tax, Docs Clear the Hurdle!"

✅ 3. Special Situation Handling

🌍 5. Global Main Market Clearance Comparison (2026 Latest)

📌 Conclusion: * USA is the market with explicit surtaxes (10%) for these codes from China in this dataset. * Regulatory Compliance (FDA) is just as important as the tax rate. A misclassified or undocumented drug shipment will be seized regardless of the low 0% base tariff.

📌 6. Common Errors & Pitfall Avoidance Guide (Blood-Teaching Lessons)

❌ Error 1: Declaring Finished Drugs as Bulk Chemicals (3003) 👉 Consequence: Customs/FDA rejects the entry because 3003 items are not intended for retail. Shipment Held.

❌ Error 2: Using vague names like "Supplement" for a Medicament 👉 Consequence: If it contains active pharmaceutical ingredients (APIs), it is not a supplement. Misdeclaration Fine.

❌ Error 3: Ignoring the Section 122 10% Surtax 👉 Consequence: Underpayment of duties. Back Taxes + Penalties.

❌ Error 4: Lack of FDA Documentation 👉 Consequence: CBP transfers the file to FDA for inspection. Delays of weeks/months.

✅ Correct Practice:

"Medicament: Amoxicillin Trihydrate, 500mg Capsules, 100ct, Rx Only, FDA Listed Facility, Model: AMX-500"

🎯 7. Conclusion: Professional Declaration, Time-Saving, Cost-Effective!

🎯 Remember the Mnemonic:

🔹 "Finished? Go 3004. Bulk? Go 3003. Origin China? 10% Surcharge. Docs Complete? Clearance Smooth!" 🔹 "HS Code Decides the Category, Surcharge Decides the Cost, FDA Decides the Entry!"

📌 Pro Tip:

If your medicaments are originally manufactured in the US or third-party countries (not China), the 10% Section 122 surtax does not apply. The rate may drop to 0%. Always verify the Country of Origin on your Certificate of Origin.

Recommendation: Apply for an Advance Ruling from CBP if the classification is ambiguous (e.g., borderline supplement/drug), to mitigate future risk.

📣 Immediate Action:

📞 Contact a Licensed Customs Broker + Provide Product Specs + Verify FDA Status 🚀 Let your medicaments pass customs smoothly, comply with regulations, and protect your profit margin!

✨ Professional Clearance Starts with Accurate Classification! 💼 Every Dollar of Duty Deserves Precise Calculation!